5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
Current non-invasive tumor biomarkers failed to accurately identify patients with colorectal cancer (CRC), delaying CRC diagnosis and thus leading to poor prognosis. Dysregulation of 5-Methylcytosine (m5C) RNA has gradually been reported in various cancers, but their role in tumor diagnosis is rarel...
Glavni autori: | , , , , , , , , , |
---|---|
Format: | Članak |
Jezik: | English |
Izdano: |
Frontiers Media S.A.
2022-09-01
|
Serija: | Frontiers in Immunology |
Teme: | |
Online pristup: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.967921/full |